Cargando…
Association between bisphosphonate use and COVID-19 related outcomes
BACKGROUND: Although there are several efficacious vaccines against COVID-19, vaccination rates in many regions around the world remain insufficient to prevent continued high disease burden and emergence of viral variants. Repurposing of existing therapeutics that prevent or mitigate severe COVID-19...
Autores principales: | Thompson, Jeffrey, Wang, Yidi, Dreischulte, Tobias, Barreiro, Olga, Gonzalez, Rodrigo J, Hanč, Pavel, Matysiak, Colette, Neely, Harold R, Rottenkolber, Marietta, Haskell, Thomas, Endres, Stefan, von Andrian, Ulrich H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691801/ https://www.ncbi.nlm.nih.gov/pubmed/37534876 http://dx.doi.org/10.7554/eLife.79548 |
Ejemplares similares
-
EPH55 Association Between Prior Bisphosphonate Use and COVID-19-Related Outcomes
por: Thompson, J, et al.
Publicado: (2022) -
Control of myeloid cell functions by nociceptors
por: Hanč, Pavel, et al.
Publicado: (2023) -
Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND Survey
por: Haerdtlein, Annette, et al.
Publicado: (2022) -
Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis
por: Haerdtlein, Annette, et al.
Publicado: (2023) -
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls
por: Chang, Yu-mei, et al.
Publicado: (2009)